工程T细胞和巨细胞:两只手臂抓住固体瘤
Luigi Russo1, Ilaria De Martino1, Matteo Marchetti1
1Istituto Italiano di Tecnologia - IIT, Largo Barsanti e Matteucci 53, Naples, Italy.
Current opinion in biotechnology
|March 27, 2025
概括
转基因免疫细胞,如CAR T细胞,显示出治疗血液癌症的前景. 设计新的功能和结合细胞类型可能会克服固体瘤免疫治疗的挑战.
科学领域:
- 免疫学 免疫学 免疫学
- 生物技术是生物技术.
- 在瘤学瘤学.
背景情况:
- 化学抗原受体 (CAR) T细胞疗法在血液性恶性瘤中取得了成功.
- 显著的障碍阻碍了CAR T细胞对固体瘤的疗效,需要加强安全性,迁移和持久性的功能.
- 巨细胞提供互补的抗瘤特性,包括细胞和抗原呈现,以获得更广泛的免疫反应.
研究的目的:
- 提供当前基于细胞的免疫疗法技术的全面概述.
- 提出免疫细胞之间的合成相互作用作为改善癌症治疗的未来突破.
- 为突出克服固体瘤免疫治疗挑战的策略.
主要方法:
- 对转基因免疫细胞疗法近期进展的回顾.
- 分析工程免疫细胞的策略,包括T细胞和巨细胞.
- 在免疫治疗中探索合成生物学方法的细胞-细胞通信.
主要成果:
- 在固体瘤中,CAR T细胞疗法面临着挑战,需要额外的工程功能.
- 巨细胞具有可以增强抗瘤免疫反应的特性.
- 目前的研究重点是增强免疫细胞的能力,以实现更广泛的治疗应用.
结论:
- 不同免疫细胞之间的工程合成相互作用是基于细胞的免疫疗法的有希望的下一步.
- 这种方法旨在开发更安全,更有效的生存疗法来治疗癌症.
- 克服固体瘤障碍需要创新的策略,超越传统的CAR T细胞疗法.
相关概念视频
Cell-mediated Immune Responses
Overview
The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.


